The link you posted says that the 90% is to treat all "chronic and mental health conditions," which is a much larger grouping than just obesity/metabolic disease.
Unlike in the United States, an injunction is the standard remedy in a patent infringement action in Germany. The idea is that Apple (the enjoined party) could subsequently negotiate a royalty with Qualcomm if it wished to have the injunction lifted.
The United States has moved away from this approach on public interest grounds (i.e., that it would not make sense to prevent the public from buying certain Apple products if those sales aren't preventing Qualcomm from selling its own competing products).